FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Alcon, B&L Settle Ad Suit

[ Price : $8.95]

Alcon says it will change promotional materials to resolve a suit filed by Bausch & Lomb on its ReNu MultiPlus disinfecting soluti...

FDA Orphan Status for Cephalon Leukemia Drug

[ Price : $8.95]

FDA grants orphan drug status to Cephalon for its investigational therapy Treanda, indicated for treating chronic lymphocytic leuk...

Forest Nixes Desmoteplase Partnership with Paion

[ Price : $8.95]

Forest Labs terminates a co-development partnership with Germanys Paion AG for desmoteplase based on disappointing Phase 3 results...

Commissioners Statement Reflects Restructuring

[ Price : $8.95]

Federal Register: FDA amends the commissioners statement of organizations, functions, and delegations of authority to reflect the ...

FDA Corrects Notice on CLIA

[ Price : $8.95]

Federal Register Notice: FDA corrects small errors in a notice announcing submission of a collection of information on clinical la...

Abbott Deleting Safety Info on Wikipedia, Group Charges

[ Price : $8.95]

A patient advocacy group charges that Abbott employees have edited over 1,000 online Wikipedia entries involving some of the compa...

Boston Scientific Paying $16.75 Million to End Probe

[ Price : $8.95]

Three Boston Scientific subsidiaries will pay $16.75 million to settle a probe by state attorneys general into three cardiac devic...

FDA Fast Track for Oral Azacitidine

[ Price : $8.95]

FDA grants fast track status to Pharmion Corp. for oral azacitidine and its use in treating Myelodysplastic Syndromes.

FDA Accepts Merck NDA on Cordaptive ER

[ Price : $8.95]

FDA accepts for review a Merck NDA for Cordaptive ER, indicated for use as monotherapy or in combination with a statin for treatin...

Celebrity Drug Ad Endorsements Banned in China

[ Price : $8.95]

China says it will ban celebrity endorsements of drugs and some other consumer products in an effort to improve product quality an...